| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.002 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |